Amy VandenBerg, PharmD

Dr. VandenBerg received her BS in Biological Psychology (1994) and her PharmD (1999) from the University of Michigan. She then completed PGY1 Pharmacy and PGY2 Psychiatric Pharmacy residencies at the Medical University of South Carolina (MUSC) and has been a Board Certified Psychiatric Pharmacist since 2001. In 2002, she took on the role of Pharmacy Clinical and Operations Coordinator for the MUSC Institute of Psychiatry and served as Residency Program Director from 2003 through 2016. In 2016, Dr. VandenBerg returned to Michigan as an inpatient clinical specialist for psychiatry and neurology services and established the PGY2 Psychiatric Pharmacy Residency. In 2020, Dr. VandenBerg joined the College of Pharmacy as Clinical Associate Professor. She serves as Senior Editor for the journal Mental Health Clinician and Assistant Editor for the DiPiro textbook Pharmacotherapy, A Pathophysiologic Approach. Her research interests include demonstrating the impact of psychiatric pharmacists and expanding clinical pharmacy services on patinet outcomes.

Ernst K, Thompson AN, VandenBerg A. Relative exposure to psychiatric conditions and medications in pharmacy education. Currents in Pharmacy Teaching and Learning. Online December 29, 2023. DOI: 10.1016/j.cptl.2023.12.016

VandenBerg, AM. An update on recently approved long-acting injectable antipsychotics: Knowns and unknowns regarding their use. Mental Health Clinician. 2022;12(5):270-281. doi: 10.9740/mhc.2022.20.270.

Wartman CC, VandenBerg A. Valproate: Not all boxed warnings are created equal. Ann Pharmacother. 2022;56(12):1349-1355.

Winder GS, Andrews SR. Banerjee AG, Hussain F, Ivkovic A, Kuntz K, Omary L, Rasimas JJ, Shenoy A, Thant T, VandenBerg A, Zimbrean P. Cannabinoid and solid organ transplantation: psychiatric perspectives and recommendations. Transplantation Reviews.2022;36(4). https://doi.org/10.1016/j.trre.2022.100715